Little difference in treatment outcome for myocardial infarction between prehospital fibrinolysis or emergency angioplasty has been found in a multicentre trial by French clinicians.
Although prehospital fibrinolysis and primary angioplasty provide a clinical benefit over in-hospital fibrinolysis, these two strategies for the treatment of severe MI have not been directly compared, points out Dr. Eric Bonnefoy and colleagues from University Hospital, Lyon, France.
The trial was coordinated by the Hospices Civils de Lyon, among 27 French tertiary hospitals and their affiliated mobile emergency-care units. Each hospital was required to have experience in routine primary angioplasty for myocardial infarction and to have a 24 hour on-call angioplasty team available.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!